Skip to main content
Top
Published in: Current Oncology Reports 4/2024

19-03-2024 | Cytostatic Therapy | REVIEW

Oral Complications and Management Strategies for Cancer Patients: Principles of Supportive Oncology in Dentistry

Authors: Susell Parra-Rojas, Rocío Trinidad Velázquez-Cayón, Acorán Borges-Gil, Juan Luis Mejías-Torrus, Juliana Cassol-Spanemberg

Published in: Current Oncology Reports | Issue 4/2024

Login to get access

Abstract

Purpose of Review

It is recognized that patients undergoing cancer treatment experience different adverse effects depending on the type of therapy they received. The objective of this work is to provide a scientific evidence-based protocol for oral care in cancer patients. Cancer resection surgery, chemotherapy, and radiotherapy can cause important complications that impact patients’ quality of life.

Recent Findings

Cancer patients, from the moment of diagnosis to the end of treatment and subsequent follow-up, have diverse care needs, both from a systemic and local point of view. The implementation of oral care protocols before, during, and after cancer therapy is essential because it helps to identify risk factors for the development of predictable oral complications.

Summary

It is essential to establish that all cancer patients, before starting treatment, undergo a systematic dental check-up to avoid limitations during treatment and also alter their quality of life. Regular professional oral care maintenance and follow-up programs are essential to maintaining a patient’s long-term oral health.
Literature
13.
go back to reference Rosenthal DI, Mendoza TR, Fuller CD, Hutcheson KA, Wang XS, Hanna EY, Lu C, Garden AS, Morrison WH, Cleeland CS, Gunn GB. Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: a prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module. Cancer. 2014;120(13):1975–84. https://doi.org/10.1002/cncr.28672.CrossRefPubMed Rosenthal DI, Mendoza TR, Fuller CD, Hutcheson KA, Wang XS, Hanna EY, Lu C, Garden AS, Morrison WH, Cleeland CS, Gunn GB. Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: a prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module. Cancer. 2014;120(13):1975–84. https://​doi.​org/​10.​1002/​cncr.​28672.CrossRefPubMed
14.
go back to reference Jensen SB, Pedersen AM, Vissink A, Andersen E, Brown CG, Davies AN, Dutilh J, Fulton JS, Jankovic L, Lopes NN, Mello AL, Muniz LV, Murdoch-Kinch CA, Nair RG, Napeñas JJ, Nogueira-Rodrigues A, Saunders D, Stirling B, von Bültzingslöwen I, Weikel DS, Elting LS, Spijkervet FK, Brennan MT; Salivary Gland Hypofunction/Xerostomia Section, Oral Care Study Group (2010) Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO). A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life. Support Care Cancer. 18(8):1039–60. https://doi.org/10.1007/s00520-010-0827-8 Jensen SB, Pedersen AM, Vissink A, Andersen E, Brown CG, Davies AN, Dutilh J, Fulton JS, Jankovic L, Lopes NN, Mello AL, Muniz LV, Murdoch-Kinch CA, Nair RG, Napeñas JJ, Nogueira-Rodrigues A, Saunders D, Stirling B, von Bültzingslöwen I, Weikel DS, Elting LS, Spijkervet FK, Brennan MT; Salivary Gland Hypofunction/Xerostomia Section, Oral Care Study Group (2010) Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO). A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life. Support Care Cancer. 18(8):1039–60. https://​doi.​org/​10.​1007/​s00520-010-0827-8
15.••
go back to reference McCaul LK, Barclay S, Nixon P, Yule PL, Trainor J, Stevenson B, Paterson A, Nicol A, Keys W, Donachie M, Barker D, Rollings S, Killough S, Ban J, Chatzipantelis A, Gaitonde P, Ranka M, Ali Z, MacInnes A, Taylor C, Gopakumar A, Sharma P, Harper V, Rasaratnam L, Toor I, Rodriguez JM. Oral prehabilitation for patients with head and neck cancer: getting it right - the Restorative Dentistry-UK consensus on a multidisciplinary approach to oral and dental assessment and planning prior to cancer treatment. Br Dent J. 2022;233(9):794–800. https://doi.org/10.1038/s41415-022-5197-3. This study gives guidelines to follow on the treatments that we should perform before starting cancer treatment.CrossRefPubMedPubMedCentral McCaul LK, Barclay S, Nixon P, Yule PL, Trainor J, Stevenson B, Paterson A, Nicol A, Keys W, Donachie M, Barker D, Rollings S, Killough S, Ban J, Chatzipantelis A, Gaitonde P, Ranka M, Ali Z, MacInnes A, Taylor C, Gopakumar A, Sharma P, Harper V, Rasaratnam L, Toor I, Rodriguez JM. Oral prehabilitation for patients with head and neck cancer: getting it right - the Restorative Dentistry-UK consensus on a multidisciplinary approach to oral and dental assessment and planning prior to cancer treatment. Br Dent J. 2022;233(9):794–800. https://​doi.​org/​10.​1038/​s41415-022-5197-3This study gives guidelines to follow on the treatments that we should perform before starting cancer treatment.CrossRefPubMedPubMedCentral
23.
go back to reference Spolidorio DMP, Spolidorio LC, Barbeiro RH, Höfling JF, Bernanrdo WLC, Pavan S. Quantitative evaluation of streptococcus mutans and candida sp and salivary factors in the oral cavity of patients submitted to radiotherapy. Pesqui Odontol Bras. 2001;15:354–8. https://pubmed.ncbi.nlm.nih.gov/11787324/ Spolidorio DMP, Spolidorio LC, Barbeiro RH, Höfling JF, Bernanrdo WLC, Pavan S. Quantitative evaluation of streptococcus mutans and candida sp and salivary factors in the oral cavity of patients submitted to radiotherapy. Pesqui Odontol Bras. 2001;15:354–8. https://​pubmed.​ncbi.​nlm.​nih.​gov/​11787324/​
25.
go back to reference Lopes MA, Coletta RD, Alves FA, Abbade N, Rossi-Junior A. Recognizing and controlling the side effects of radiotherapy. Rev Assoc Paul Cir Dent. 1998;52:241–4. Lopes MA, Coletta RD, Alves FA, Abbade N, Rossi-Junior A. Recognizing and controlling the side effects of radiotherapy. Rev Assoc Paul Cir Dent. 1998;52:241–4.
26.
go back to reference Andrade CR, Lope SMP, Coletta RD, Vargas PA, Lopes MA. Endodontic treatment in patients irradiation on the head and neck region. Rev Assoc Paul Cir Dent. 2003;57:43–6. Andrade CR, Lope SMP, Coletta RD, Vargas PA, Lopes MA. Endodontic treatment in patients irradiation on the head and neck region. Rev Assoc Paul Cir Dent. 2003;57:43–6.
27.••
go back to reference Jané-Salas E, Escobar-Álvarez Y, Álvarez-García R, García-Miragall E, Clemente-Tejada L, Beorlegui-Murillo P, et al. Multidisciplinary consensus on oral care in cancer patients [Internet]. Semo.es. [cited 2023 Aug 23]. 2022. ISBN: 978–84–09–44337–6. Available from: https://semo.es/wp-content/uploads/2022/10/MULTIDISCIPLINARI-CONSENSUS_2.pdf. This study is the first publication as a multidisciplinary consensus guideline on oral care in cancer patients of important scientific societies in Spain. It is one of the most recent in the literature and serves as a guide for any oncology team that also wants to take care of the oral health of their patients. Jané-Salas E, Escobar-Álvarez Y, Álvarez-García R, García-Miragall E, Clemente-Tejada L, Beorlegui-Murillo P, et al. Multidisciplinary consensus on oral care in cancer patients [Internet]. Semo.es. [cited 2023 Aug 23]. 2022. ISBN: 978–84–09–44337–6. Available from: https://​semo.​es/​wp-content/​uploads/​2022/​10/​MULTIDISCIPLINAR​I-CONSENSUS_​2.​pdfThis study is the first publication as a multidisciplinary consensus guideline on oral care in cancer patients of important scientific societies in Spain. It is one of the most recent in the literature and serves as a guide for any oncology team that also wants to take care of the oral health of their patients.
32.
go back to reference Lopes NN, Plapler H, Chavantes MC, et al. Cyclooxygenase-2 and vascular endothelial growth factor expression in 5-fluorouracilinduced oral mucositis in hamsters: evaluation of two low-intensity laser protocols. Support Care Cancer. 2009;17(11):1409–15. https://pubmed.ncbi.nlm.nih.gov/19234862/ Lopes NN, Plapler H, Chavantes MC, et al. Cyclooxygenase-2 and vascular endothelial growth factor expression in 5-fluorouracilinduced oral mucositis in hamsters: evaluation of two low-intensity laser protocols. Support Care Cancer. 2009;17(11):1409–15. https://​pubmed.​ncbi.​nlm.​nih.​gov/​19234862/​
36.•
go back to reference Ramos-Pinto MB, de Lima Gusmão TP, Schmidt-Filho J, Jaguar GC, Martins MD, Alves FA. Intraoral versus extraoral photobiomodulation therapy in the prevention of oral mucositis in HSCT patients: a randomized, single-blind, controlled clinical trial. Support Care Cancer. 2021;29(11):6495–503. https://doi.org/10.1007/s00520-021-06228-3. This study is important because it demonstrates that extraoral application is just as effective as intraoral application and can be applied in cases of opening limitation.CrossRefPubMed Ramos-Pinto MB, de Lima Gusmão TP, Schmidt-Filho J, Jaguar GC, Martins MD, Alves FA. Intraoral versus extraoral photobiomodulation therapy in the prevention of oral mucositis in HSCT patients: a randomized, single-blind, controlled clinical trial. Support Care Cancer. 2021;29(11):6495–503. https://​doi.​org/​10.​1007/​s00520-021-06228-3. This study is important because it demonstrates that extraoral application is just as effective as intraoral application and can be applied in cases of opening limitation.CrossRefPubMed
38.
go back to reference Pagotto SR, Carvalho MB. Prevention and treatment of effects of radiotherapy in the mouth. Rev Assoc Paul Cir Dent. 2006;60:499–502. Pagotto SR, Carvalho MB. Prevention and treatment of effects of radiotherapy in the mouth. Rev Assoc Paul Cir Dent. 2006;60:499–502.
41.
go back to reference Ren H, Liu J, Liu Y, Yu C, Bao G, Kang H. Comparative effectiveness of low-level laser therapy with different wavelengths and transcutaneous electric nerve stimulation in the treatment of pain caused by temporomandibular disorders: a systematic review and network meta-analysis. J Oral Rehabil. 2022;49(2):138–49. https://doi.org/10.1111/joor.13230.CrossRefPubMed Ren H, Liu J, Liu Y, Yu C, Bao G, Kang H. Comparative effectiveness of low-level laser therapy with different wavelengths and transcutaneous electric nerve stimulation in the treatment of pain caused by temporomandibular disorders: a systematic review and network meta-analysis. J Oral Rehabil. 2022;49(2):138–49. https://​doi.​org/​10.​1111/​joor.​13230.CrossRefPubMed
47.•
go back to reference Campos L, Martins F, Tateno RY, Sendyk WR, Palma LF. Antimicrobial photodynamic therapy using optical fiber for oral fistula resulting from mandibular osteoradionecrosis. Photodiagnosis Photodyn Ther. 2021;34:102247. https://doi.org/10.1016/j.pdpdt.2021.102247. This study suggests that photobiomodulation and aPDT as new treatments for osteoradionecrosis provide significant benefits to patients, assisting in the clinical management of the disease and reducing the severity of lesions, acting as an adjunctive treatment within a set of clinical strategies.CrossRefPubMed Campos L, Martins F, Tateno RY, Sendyk WR, Palma LF. Antimicrobial photodynamic therapy using optical fiber for oral fistula resulting from mandibular osteoradionecrosis. Photodiagnosis Photodyn Ther. 2021;34:102247. https://​doi.​org/​10.​1016/​j.​pdpdt.​2021.​102247This study suggests that photobiomodulation and aPDT as new treatments for osteoradionecrosis provide significant benefits to patients, assisting in the clinical management of the disease and reducing the severity of lesions, acting as an adjunctive treatment within a set of clinical strategies.CrossRefPubMed
Metadata
Title
Oral Complications and Management Strategies for Cancer Patients: Principles of Supportive Oncology in Dentistry
Authors
Susell Parra-Rojas
Rocío Trinidad Velázquez-Cayón
Acorán Borges-Gil
Juan Luis Mejías-Torrus
Juliana Cassol-Spanemberg
Publication date
19-03-2024
Publisher
Springer US
Published in
Current Oncology Reports / Issue 4/2024
Print ISSN: 1523-3790
Electronic ISSN: 1534-6269
DOI
https://doi.org/10.1007/s11912-024-01518-5

Other articles of this Issue 4/2024

Current Oncology Reports 4/2024 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine